KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression

Background: The origin and mechanisms of chromosomal instability are still widely unknown. We previously investigated a limited number of human sporadic colorectal cancers (CRCs) and observed a statistically different occurrence of KRAS and p53 mutations among predetermined subgroups of tumors with...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniele Calistri, Claudia Rengucci, Ian Seymour, Elena Leonardi, Mauro Truini, Davide Malacarne, Patrizio Castagnola, Walter Giaretti
Format: Article
Language:English
Published: Wiley 2006-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.1155/2006/465050
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562087111426048
author Daniele Calistri
Claudia Rengucci
Ian Seymour
Elena Leonardi
Mauro Truini
Davide Malacarne
Patrizio Castagnola
Walter Giaretti
author_facet Daniele Calistri
Claudia Rengucci
Ian Seymour
Elena Leonardi
Mauro Truini
Davide Malacarne
Patrizio Castagnola
Walter Giaretti
author_sort Daniele Calistri
collection DOAJ
description Background: The origin and mechanisms of chromosomal instability are still widely unknown. We previously investigated a limited number of human sporadic colorectal cancers (CRCs) and observed a statistically different occurrence of KRAS and p53 mutations among predetermined subgroups of tumors with different degrees of DNA aneuploidy. The aim of the present study was to further verify these observations by including BRAF gene analysis and by investigating a larger series of cases subdivided into Dukes' stages A to D to reconstruct some form of chronological modulation for events during CRC progression. Methods: KRAS, p53, BRAF mutations and flow cytometric DNA Index were evaluated by established techniques in a series of 135 human sporadic CRCs. Results: p53, KRAS and BRAF mutations were found in 39%, 34%, and 4% of tumors, respectively. The frequency of p53 mutations increased from 15% for stage A to 48% for stage D and was highest in near-diploid (DI 1.6) tumors. A similar correlation between gene mutations and DI values was observed for KRAS. The simultaneous presence of KRAS and p53 mutations was observed in only 11% of cases. Moreover, the co-occurrence of p53 and KRAS mutations was only observed in near-diploid and high-aneuploid tumors. Conclusion: Our findings suggest that KRAS and p53 gene mutations, which are rarely simultaneous and are associated with specific DI aneuploid values, do not represent a synergistic evolutionary pathway but may influence mechanisms of chromosomal instability.
format Article
id doaj-art-e4d0e53ec2604aa8a4e52f33ef87f19a
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2006-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-e4d0e53ec2604aa8a4e52f33ef87f19a2025-02-03T01:23:32ZengWileyCellular Oncology1570-58701875-86062006-01-0128416116610.1155/2006/465050KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer ProgressionDaniele Calistri0Claudia Rengucci1Ian Seymour2Elena Leonardi3Mauro Truini4Davide Malacarne5Patrizio Castagnola6Walter Giaretti7Department of Medical Oncology, Morgagni-Pierantoni Hospital, Forlì, ItalyDepartment of Medical Oncology, Morgagni-Pierantoni Hospital, Forlì, ItalyDepartment of Medical Oncology, Morgagni-Pierantoni Hospital, Forlì, ItalyDepartment of Pathology and Cytometry Laboratory, St. Chiara Hospital, Trento, ItalyNational Institute for Cancer Research, Genoa, ItalyNational Institute for Cancer Research, Genoa, ItalyNational Institute for Cancer Research, Genoa, ItalyNational Institute for Cancer Research, Genoa, ItalyBackground: The origin and mechanisms of chromosomal instability are still widely unknown. We previously investigated a limited number of human sporadic colorectal cancers (CRCs) and observed a statistically different occurrence of KRAS and p53 mutations among predetermined subgroups of tumors with different degrees of DNA aneuploidy. The aim of the present study was to further verify these observations by including BRAF gene analysis and by investigating a larger series of cases subdivided into Dukes' stages A to D to reconstruct some form of chronological modulation for events during CRC progression. Methods: KRAS, p53, BRAF mutations and flow cytometric DNA Index were evaluated by established techniques in a series of 135 human sporadic CRCs. Results: p53, KRAS and BRAF mutations were found in 39%, 34%, and 4% of tumors, respectively. The frequency of p53 mutations increased from 15% for stage A to 48% for stage D and was highest in near-diploid (DI 1.6) tumors. A similar correlation between gene mutations and DI values was observed for KRAS. The simultaneous presence of KRAS and p53 mutations was observed in only 11% of cases. Moreover, the co-occurrence of p53 and KRAS mutations was only observed in near-diploid and high-aneuploid tumors. Conclusion: Our findings suggest that KRAS and p53 gene mutations, which are rarely simultaneous and are associated with specific DI aneuploid values, do not represent a synergistic evolutionary pathway but may influence mechanisms of chromosomal instability.http://dx.doi.org/10.1155/2006/465050
spellingShingle Daniele Calistri
Claudia Rengucci
Ian Seymour
Elena Leonardi
Mauro Truini
Davide Malacarne
Patrizio Castagnola
Walter Giaretti
KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression
Cellular Oncology
title KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression
title_full KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression
title_fullStr KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression
title_full_unstemmed KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression
title_short KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression
title_sort kras p53 and braf gene mutations and aneuploidy in sporadic colorectal cancer progression
url http://dx.doi.org/10.1155/2006/465050
work_keys_str_mv AT danielecalistri krasp53andbrafgenemutationsandaneuploidyinsporadiccolorectalcancerprogression
AT claudiarengucci krasp53andbrafgenemutationsandaneuploidyinsporadiccolorectalcancerprogression
AT ianseymour krasp53andbrafgenemutationsandaneuploidyinsporadiccolorectalcancerprogression
AT elenaleonardi krasp53andbrafgenemutationsandaneuploidyinsporadiccolorectalcancerprogression
AT maurotruini krasp53andbrafgenemutationsandaneuploidyinsporadiccolorectalcancerprogression
AT davidemalacarne krasp53andbrafgenemutationsandaneuploidyinsporadiccolorectalcancerprogression
AT patriziocastagnola krasp53andbrafgenemutationsandaneuploidyinsporadiccolorectalcancerprogression
AT waltergiaretti krasp53andbrafgenemutationsandaneuploidyinsporadiccolorectalcancerprogression